Welcome to ResMed.com
This area of our site caters to our commercial partners.
This product may not be available in all countries.
The S9 AutoSet™ is ResMed's premium auto-adjusting device, designed to help patients comfortably adjust to sleep apnoea therapy and encourage long-term compliance.
The S9 AutoSet responds to flow limitation to pre-emptively treat apnoea events and prevent more serious, subsequent events from occurring. Using ResMed's enhanced AutoSet technology, it automatically adjusts breath by breath, as a patients respiratory needs change - hourly, nightly and from season to season - to deliver the lowest therapeutic pressure. As a result, the AutoSet algorithm has been clinically proven to increase patient comfort and compliance.1-3
Our S9 devices integrate seamlessly with the H5iTM heated humidifier with Climate Control, which works to maintain ideal humidification and temperature settings to help reduce the occurrence of condensation and minimise side effects such as dry throat or mouth.
The user-friendly controls and intuitive interface guide patients through the setup process, and extra features like SmartStart™ and Mask Fit are an added convenience.
Please contact our Customer Service department to speak to a ResMed representative
Premium auto-adjusting pressure therapy device.
Premium auto-adjusting pressure device specifically for female patients.
The S9 Elite™ is the premium CPAP device in ResMed's S9 Series.
The S9 Escape is the standard CPAP device in ResMed's S9 Series.
Hukins C. Comparative study of autotitrating and fixed-pressure CPAP in the home: a randomized, single-blind crossover trial. Sleep. 2004 Dec 15;27(8):1512-7. This was an industry supported study by ResMed Australia. Dr. Hukins received research equipment from ResMed Australia.
Massie CA, McArdle N, Hart RW, Schmidt-Nowara WW, Lankford A, Hudgel DW, Gordon N, Douglas NJ. Comparison between automatic and fixed positive airway pressure therapy in the home. Am J Respir Crit Care Med. 2003 Jan 1;167(1):20-3. Supported by a grant from ResMed Corporation.